- Best Practices New Normal
- Digital Dentistry
- Data Security
- Implants
- Catapult Education
- COVID-19
- Digital Imaging
- Laser Dentistry
- Restorative Dentistry
- Cosmetic Dentistry
- Periodontics
- Oral Care
- Evaluating Dental Materials
- Cement and Adhesives
- Equipment & Supplies
- Ergonomics
- Products
- Dentures
- Infection Control
- Orthodontics
- Technology
- Techniques
- Materials
- Emerging Research
- Pediatric Dentistry
- Endodontics
- Oral-Systemic Health
AXIM Biotech unveils world's first cannabigerol oral care & cosmetic products
New York-based AXIM Biotechnologies, Inc. presented its line of the world's first oral care and cosmetic products that include cannabigerol (CBG).
New York-based AXIM Biotechnologies, Inc. presented its line of the world's first oral care and cosmetic products that include cannabigerol (CBG).
"In 2015, these products will come to market and provide cutting-edge health and beauty options for consumers," said George E. Anastassov, MD, DDS, MBA and chief executive officer for AXIM Biotechnologies. "The toothpaste market is a $20 billion industry, and the cosmetics market is a $420 billion industry. So we do not consider other brands as our competitors. There's plenty of room to go around."
The following is a list of several retail-ready CBG hemp cannabis-infused products from AXIM Biotech:
- Toothpaste
- Mouthwash
- Dentifrice
- Oral gel (for minor cuts and sores)
- Diaper rash cream
- Moisturizers
- Lotions
- Lip balm
- Shampoo
- Conditioner
- Body Wash
- Day Cream
- Night Cream
- Eye Cream
All of the products unveiled by AXIM Biotech are said to be tested and free of heavy metals, pesticides, fungi or bacteria.
"We use only pharmaceutical-grade cannabinoid products," Anastassov said. "There are no irritants. Everything is 100-percent natural."
Complete use of the industrial hemp plant is at the core of the company's business plan, which aims to use the natural plant to benefit human health while providing clean alternative energy and delivering many other innovative applications. By focusing efforts on unique proprietary delivery mechanisms for the introduction of cannabinoids, AXIM Biotechnologies is actively developing solutions for conditions for which there reportedly are no effective treatments.
AXIM Biotech also creates strategic partnerships and acquisitions, allowing ongoing research and development in the areas of functional foods, nutraceuticals, pharmaceuticals, cosmetics and clean energy-all derived from the industrial hemp plant.
For more information, visit AXIM Biotech's website at aximbiotech.com.
